Demand in the US for pharmaceutical chemicals is forecast to rise 6.5 percent annually, reaching $46.9 billion in 2019. Key trends that will drive growth include advancements in treatment for cancer, diabetes, healthcare-associated infections, heart failure, and Alzheimer’s.
This report breaks out the pharmaceutical chemical market by therapeutic group. Demand is provided in million US dollars.
Therapeutic groups include:
Central Nervous System
Hormones and Related
Central nervous system active ingredients, which are the largest product group served by pharmaceutical chemicals, will experience above average annual sales growth due to increased generic drug competition and the development of new therapeutic entities. The fastest gains will be achieved by hormones and related agents, spurred by increased demand for active ingredients of antidiabetic, hormone replacement, and anticancer therapies.
Broken out by chemical type, this study features historical demand data for 2004, 2009, and 2014; and presents forecasts for 2019 and 2024. Additionally, the study includes profiles, sales estimates, and market share for 31 key participant companies.
Participant companies include:
Disman Pharmaceuticals and Chemicals
Johnson & Johnson
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries